Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SABR-CaRe: A Phase II Randomized Trial of Pre-Operative Stereotactic Ablative Radiation Therapy (SABR) With and Without Caloric Restriction for Early Stage Breast Cancer

NCT04959474 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT04959474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04959474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SABR-CaRe: A Phase II Randomized Trial of Pre-Operative Stereotactic Ablative Radiation Therapy (SABR) With and Without Caloric Restriction for Early Stage Breast Cancer
Lead sponsor
Thomas Jefferson University
Phase
Not applicable
Overall status
Recruiting
Start date
August 23, 2021
Completion date
November 1, 2028
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage 0 breast cancer ajcc v8, anatomic stage 1 breast cancer ajcc v8, anatomic stage 2 breast cancer ajcc v8, anatomic stage 3 breast cancer ajcc v8, breast ductal carcinoma in situ, invasive breast carcinoma, triple negative breast carcinoma